Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian Carcinoma

Mucinous epithelial ovarian cancer (mEOC) is a rare subset of epithelial ovarian cancer. When diagnosed at a late stage, its prognosis is very poor, as it is quite chemo-resistant. To find new therapeutic options for mEOC, we performed high-throughput screening using a siRNA library directed against...

Descripción completa

Detalles Bibliográficos
Autores principales: Affatato, Roberta, Carrassa, Laura, Chilà, Rosaria, Lupi, Monica, Restelli, Valentina, Damia, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140026/
https://www.ncbi.nlm.nih.gov/pubmed/32183025
http://dx.doi.org/10.3390/cancers12030672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140026/
https://www.ncbi.nlm.nih.gov/pubmed/32183025
http://dx.doi.org/10.3390/cancers12030672

Ejemplares similares